newsfilter
← Latest News
GlobeNewswire·

Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026

NEWTON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS), ("Acumen" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics that